{"entity":{"type":"insider","cik":"0001565089","url":"/insider/0001565089","json_url":"/insider/0001565089.json","name":"Deerfield International Master Fund, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":304,"n_filings":40,"first":"2014-08-05","last":"2017-12-04","span_basis":"filed_date"},"name_variants":[{"name":"Deerfield International Master Fund, L.P.","source":"filing","n_filings":40,"first_seen":"2014-08-05","last_seen":"2017-12-04"}],"transactions":[{"id":4858433,"accession":"0001193805-17-003553","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-17-003553","line_url":"/filing/0001193805-17-003553#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"PROTEON THERAPEUTICS INC","issuer_ticker":"PRTO","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield International Master Fund, L.P.; Deerfield Mgmt L.P.; DEERFIELD PARTNERS, L.P.; Flynn James E","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110557.0,"shares_display":"110,557","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":193474.75,"total_display":"193,474.75","total_whole":"193,475","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-04","scope":"insider"},{"id":4858428,"accession":"0001193805-17-003553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-17-003553","line_url":"/filing/0001193805-17-003553#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"PROTEON THERAPEUTICS INC","issuer_ticker":"PRTO","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield International Master Fund, L.P.; Deerfield Mgmt L.P.; DEERFIELD PARTNERS, L.P.; Flynn James E","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Director, Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":110557.0,"shares_display":"110,557","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":193474.75,"total_display":"193,474.75","total_whole":"193,475","shares_owned_after":197424.0,"shares_owned_after_display":"197,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-04","scope":"insider"},{"id":4474903,"accession":"0001193805-17-001110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-17-001110","line_url":"/filing/0001193805-17-001110#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield International Master Fund, L.P.; Deerfield Mgmt L.P.; Flynn James E; DEERFIELD MANAGEMENT CO; Deerfield Special Situations Fund, L.P.","owner_display_name":"DEERFIELD PARTNERS, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68000.0,"shares_display":"68,000","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":425000.0,"total_display":"425,000.00","total_whole":"425,000","shares_owned_after":1176685.0,"shares_owned_after_display":"1,176,685","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-14","filed_date":"2017-06-14","scope":"insider"},{"id":4474898,"accession":"0001193805-17-001110","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-17-001110","line_url":"/filing/0001193805-17-001110#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield International Master Fund, L.P.; Deerfield Mgmt L.P.; Flynn James E; DEERFIELD MANAGEMENT CO; Deerfield Special Situations Fund, L.P.","owner_display_name":"DEERFIELD PARTNERS, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32447.0,"shares_display":"32,447","price_per_share":6.59,"price_display":"6.59","price_state":"stated","total_value":213825.73,"total_display":"213,825.73","total_whole":"213,826","shares_owned_after":1244685.0,"shares_owned_after_display":"1,244,685","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-13","filed_date":"2017-06-14","scope":"insider"},{"id":4474891,"accession":"0001193805-17-001110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-17-001110","line_url":"/filing/0001193805-17-001110#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield International Master Fund, L.P.; Deerfield Mgmt L.P.; Flynn James E; DEERFIELD MANAGEMENT CO; Deerfield Special Situations Fund, L.P.","owner_display_name":"DEERFIELD PARTNERS, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":6.74,"price_display":"6.74","price_state":"stated","total_value":67400.0,"total_display":"67,400.00","total_whole":"67,400","shares_owned_after":1277132.0,"shares_owned_after_display":"1,277,132","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-12","filed_date":"2017-06-14","scope":"insider"},{"id":4253292,"accession":"0001193805-17-001069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-17-001069","line_url":"/filing/0001193805-17-001069#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E; DEERFIELD PARTNERS, L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17245.0,"shares_display":"17,245","price_per_share":6.99,"price_display":"6.99","price_state":"stated","total_value":120542.55,"total_display":"120,542.55","total_whole":"120,543","shares_owned_after":1287132.0,"shares_owned_after_display":"1,287,132","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-08","filed_date":"2017-06-09","scope":"insider"},{"id":4253288,"accession":"0001193805-17-001069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-17-001069","line_url":"/filing/0001193805-17-001069#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E; DEERFIELD PARTNERS, L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45623.0,"shares_display":"45,623","price_per_share":7.09,"price_display":"7.09","price_state":"stated","total_value":323467.07,"total_display":"323,467.07","total_whole":"323,467","shares_owned_after":1304377.0,"shares_owned_after_display":"1,304,377","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-07","filed_date":"2017-06-09","scope":"insider"},{"id":4214348,"accession":"0001193805-17-000705","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-17-000705","line_url":"/filing/0001193805-17-000705","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.; DEERFIELD MANAGEMENT CO; DEERFIELD PARTNERS, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E","owner_display_name":"Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":313709.0,"shares_display":"313,709","price_per_share":11.71,"price_display":"11.71","price_state":"stated","total_value":3673532.39,"total_display":"3,673,532.39","total_whole":"3,673,532","shares_owned_after":244562.0,"shares_owned_after_display":"244,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-27","filed_date":"2017-04-27","scope":"insider","n_lines":3},{"id":4214334,"accession":"0001193805-17-000705","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-17-000705","line_url":"/filing/0001193805-17-000705","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.; DEERFIELD MANAGEMENT CO; DEERFIELD PARTNERS, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E","owner_display_name":"Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":113245.0,"shares_display":"113,245","price_per_share":11.52,"price_display":"11.52","price_state":"stated","total_value":1304582.4,"total_display":"1,304,582.40","total_whole":"1,304,582","shares_owned_after":428367.0,"shares_owned_after_display":"428,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-26","filed_date":"2017-04-27","scope":"insider","n_lines":3},{"id":4193782,"accession":"0001193805-17-000651","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-17-000651","line_url":"/filing/0001193805-17-000651","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield Special Situations Fund, L.P.; Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.; DEERFIELD PARTNERS, L.P.; Flynn James E","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1650000.0,"total_display":"1,650,000.00","total_whole":"1,650,000","shares_owned_after":494718.0,"shares_owned_after_display":"494,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-13","filed_date":"2017-04-17","scope":"insider","n_lines":3},{"id":4538332,"accession":"0001193805-17-000620","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193805-17-000620","line_url":"/filing/0001193805-17-000620","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield International Master Fund, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33440.0,"shares_display":"33,440","price_per_share":11.0125,"price_display":"11.01","price_state":"stated","total_value":368258.0,"total_display":"368,258.00","total_whole":"368,258","shares_owned_after":582604.0,"shares_owned_after_display":"582,604","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-11","filed_date":"2017-04-11","scope":"insider","n_lines":3},{"id":4538323,"accession":"0001193805-17-000620","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-17-000620","line_url":"/filing/0001193805-17-000620","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield International Master Fund, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79757.0,"shares_display":"79,757","price_per_share":11.0375,"price_display":"11.04","price_state":"stated","total_value":880317.8875,"total_display":"880,317.89","total_whole":"880,318","shares_owned_after":602197.0,"shares_owned_after_display":"602,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-10","filed_date":"2017-04-11","scope":"insider","n_lines":3},{"id":4538311,"accession":"0001193805-17-000620","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-17-000620","line_url":"/filing/0001193805-17-000620","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield International Master Fund, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118904.0,"shares_display":"118,904","price_per_share":11.7163,"price_display":"11.72","price_state":"stated","total_value":1393114.9352,"total_display":"1,393,114.94","total_whole":"1,393,115","shares_owned_after":648927.0,"shares_owned_after_display":"648,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-07","filed_date":"2017-04-11","scope":"insider","n_lines":3},{"id":3287492,"accession":"0001193805-16-004027","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-16-004027","line_url":"/filing/0001193805-16-004027","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Flynn James E; DEERFIELD PARTNERS, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":779497.0,"shares_display":"779,497","price_per_share":16.707,"price_display":"16.71","price_state":"stated","total_value":13023056.379,"total_display":"13,023,056.38","total_whole":"13,023,056","shares_owned_after":2035697.0,"shares_owned_after_display":"2,035,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-23","filed_date":"2016-09-26","scope":"insider","n_lines":3},{"id":3287481,"accession":"0001193805-16-004027","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-16-004027","line_url":"/filing/0001193805-16-004027","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Flynn James E; DEERFIELD PARTNERS, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":340964.0,"shares_display":"340,964","price_per_share":16.239,"price_display":"16.24","price_state":"stated","total_value":5536914.396,"total_display":"5,536,914.40","total_whole":"5,536,914","shares_owned_after":2383955.0,"shares_owned_after_display":"2,383,955","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-22","filed_date":"2016-09-26","scope":"insider","n_lines":3},{"id":3164660,"accession":"0001193805-16-003980","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193805-16-003980","line_url":"/filing/0001193805-16-003980","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; DEERFIELD PARTNERS, L.P.; Deerfield International Master Fund, L.P.; Deerfield Mgmt L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45811.0,"shares_display":"45,811","price_per_share":15.570048590949773,"price_display":"15.57","price_state":"stated","total_value":713279.496,"total_display":"713,279.50","total_whole":"713,279","shares_owned_after":919718.0,"shares_owned_after_display":"919,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-19","filed_date":"2016-09-19","scope":"insider","n_lines":3},{"id":3164652,"accession":"0001193805-16-003980","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-16-003980","line_url":"/filing/0001193805-16-003980","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; DEERFIELD PARTNERS, L.P.; Deerfield International Master Fund, L.P.; Deerfield Mgmt L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300372.0,"shares_display":"300,372","price_per_share":15.619,"price_display":"15.62","price_state":"stated","total_value":4691510.268,"total_display":"4,691,510.27","total_whole":"4,691,510","shares_owned_after":2541199.0,"shares_owned_after_display":"2,541,199","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-16","filed_date":"2016-09-19","scope":"insider","n_lines":3},{"id":3164645,"accession":"0001193805-16-003980","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-16-003980","line_url":"/filing/0001193805-16-003980","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; DEERFIELD PARTNERS, L.P.; Deerfield International Master Fund, L.P.; Deerfield Mgmt L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201703.0,"shares_display":"201,703","price_per_share":15.755,"price_display":"15.76","price_state":"stated","total_value":3177830.765,"total_display":"3,177,830.76","total_whole":"3,177,831","shares_owned_after":2660207.0,"shares_owned_after_display":"2,660,207","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-19","scope":"insider","n_lines":3},{"id":2403694,"accession":"0001193805-16-003655","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-16-003655","line_url":"/filing/0001193805-16-003655","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ZAFGEN, INC.","issuer_ticker":"ZFGN","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.; Deerfield Special Situations Fund, L.P.; DEERFIELD MANAGEMENT CO; DEERFIELD PARTNERS, L.P.","owner_display_name":"Flynn James E","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1341499.0,"shares_display":"1,341,499","price_per_share":3.3118,"price_display":"3.31","price_state":"stated","total_value":4442776.3882,"total_display":"4,442,776.39","total_whole":"4,442,776","shares_owned_after":1151802.0,"shares_owned_after_display":"1,151,802","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-07-20","filed_date":"2016-08-01","scope":"insider","n_lines":3},{"id":3196799,"accession":"0001193805-16-003495","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-16-003495","line_url":"/filing/0001193805-16-003495#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield International Master Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.; Flynn James E; Deerfield Special Situations Fund, L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26400.0,"shares_display":"26,400","price_per_share":14.3012,"price_display":"14.30","price_state":"stated","total_value":377551.68,"total_display":"377,551.68","total_whole":"377,552","shares_owned_after":718594.0,"shares_owned_after_display":"718,594","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-21","filed_date":"2016-06-22","scope":"insider"},{"id":3196792,"accession":"0001193805-16-003495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-16-003495","line_url":"/filing/0001193805-16-003495#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Deerfield International Master Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.; Flynn James E; Deerfield Special Situations Fund, L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178454.0,"shares_display":"178,454","price_per_share":14.197,"price_display":"14.20","price_state":"stated","total_value":2533511.438,"total_display":"2,533,511.44","total_whole":"2,533,511","shares_owned_after":744994.0,"shares_owned_after_display":"744,994","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-20","filed_date":"2016-06-22","scope":"insider"},{"id":2353693,"accession":"0001193805-16-003469","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-16-003469","line_url":"/filing/0001193805-16-003469#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.; Deerfield Special Situations Fund, L.P.; DEERFIELD PARTNERS, L.P.; DEERFIELD MANAGEMENT CO","owner_display_name":"Flynn James E","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43300.0,"shares_display":"43,300","price_per_share":13.8838,"price_display":"13.88","price_state":"stated","total_value":601168.54,"total_display":"601,168.54","total_whole":"601,169","shares_owned_after":923448.0,"shares_owned_after_display":"923,448","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-14","filed_date":"2016-06-16","scope":"insider"},{"id":2499740,"accession":"0001193805-16-003439","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-16-003439","line_url":"/filing/0001193805-16-003439#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT CO; DEERFIELD PARTNERS, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E; Deerfield International Master Fund, L.P.","owner_display_name":"Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28080.0,"shares_display":"28,080","price_per_share":13.8402,"price_display":"13.84","price_state":"stated","total_value":388632.816,"total_display":"388,632.82","total_whole":"388,633","shares_owned_after":966748.0,"shares_owned_after_display":"966,748","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-08","filed_date":"2016-06-08","scope":"insider"},{"id":2499736,"accession":"0001193805-16-003439","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-16-003439","line_url":"/filing/0001193805-16-003439#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT CO; DEERFIELD PARTNERS, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E; Deerfield International Master Fund, L.P.","owner_display_name":"Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7154.0,"shares_display":"7,154","price_per_share":13.8915,"price_display":"13.89","price_state":"stated","total_value":99379.791,"total_display":"99,379.79","total_whole":"99,380","shares_owned_after":994828.0,"shares_owned_after_display":"994,828","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-08","scope":"insider"},{"id":2499732,"accession":"0001193805-16-003439","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-16-003439","line_url":"/filing/0001193805-16-003439#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt L.P.; DEERFIELD MANAGEMENT CO; DEERFIELD PARTNERS, L.P.; Deerfield Special Situations Fund, L.P.; Flynn James E; Deerfield International Master Fund, L.P.","owner_display_name":"Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28502.0,"shares_display":"28,502","price_per_share":14.0003,"price_display":"14.00","price_state":"stated","total_value":399036.5506,"total_display":"399,036.55","total_whole":"399,037","shares_owned_after":1001982.0,"shares_owned_after_display":"1,001,982","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-08","scope":"insider"},{"id":2125751,"accession":"0001193805-16-003394","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-16-003394","line_url":"/filing/0001193805-16-003394#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"eHealth, Inc.","issuer_ticker":"EHTH","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT CO; Flynn James E; DEERFIELD PARTNERS, L.P.; Deerfield Special Situations Fund, L.P.; Deerfield Mgmt L.P.; Deerfield International Master Fund, L.P.","owner_display_name":"DEERFIELD MANAGEMENT CO","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42668.0,"shares_display":"42,668","price_per_share":13.8685,"price_display":"13.87","price_state":"stated","total_value":591741.158,"total_display":"591,741.16","total_whole":"591,741","shares_owned_after":1030484.0,"shares_owned_after_display":"1,030,484","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-02","filed_date":"2016-06-02","scope":"insider"}],"collapsed":true,"next_cursor":"2016-06-02|2125751","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001359931","name":"PROTEON THERAPEUTICS INC","url":"/issuer/0001359931","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2017-12-04","last_seen":"2017-12-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001588972","name":"Recro Pharma, Inc.","url":"/issuer/0001588972","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2017-06-09","last_seen":"2017-06-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001333493","name":"eHealth, Inc.","url":"/issuer/0001333493","role":"Ten percent owner, Other","n_filings":12,"first_seen":"2014-08-05","last_seen":"2017-04-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Ten percent owner, Other","n_filings":6,"first_seen":"2014-12-24","last_seen":"2016-09-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001374690","name":"ZAFGEN, INC.","url":"/issuer/0001374690","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2016-02-11","last_seen":"2016-08-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001130591","name":"XENOPORT INC","url":"/issuer/0001130591","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2016-02-16","last_seen":"2016-02-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001652923","name":"AveXis, Inc.","url":"/issuer/0001652923","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2016-02-19","last_seen":"2016-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001016169","name":"ANTARES PHARMA, INC.","url":"/issuer/0001016169","role":"Ten percent owner, Other","n_filings":9,"first_seen":"2015-06-15","last_seen":"2015-09-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001590877","name":"REGENXBIO Inc.","url":"/issuer/0001590877","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-09-22","last_seen":"2015-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001454189","name":"Auspex Pharmaceuticals, Inc.","url":"/issuer/0001454189","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-01-28","last_seen":"2015-01-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001581720","name":"Loxo Oncology, Inc.","url":"/issuer/0001581720","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2014-08-06","last_seen":"2014-08-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Avalanche Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2014-08-05","last_seen":"2014-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001565089","retrieved_at":"2026-08-25T05:50:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}